Crossmark

LRIG2 is a growth suppressor of Hec-1A and Ishikawa endometrial adenocarcinoma cells by regulating PI3K/AKT- and EGFR-mediated apoptosis and cell-cycle

Crossref DOI link: https://doi.org/10.1038/s41389-017-0019-1

Published Online: 2018-01-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suh, Dae-Shik

Park, Si Eun

Jin, Hanyong

Lee, Kangseok

Bae, Jeehyeon
License Information

Text and Data Mining valid from 2018-01-23

Version of Record valid from 2018-01-23
More Information

Article History

Received: 20 July 2017

Accepted: 22 November 2017

First Online: 23 January 2018

Conflict of interest

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below